Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd.’s Net Profit Dropped 14.1% in 2022

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd. (通化金马药业集团股份有限公司) (000766.SZ) reported a net profit of 29.2 million yuan in 2022, down 14.1% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, down 3% year-on-year.

At the end of the reporting period, it had 4.7 billion yuan in total assets and 2.3 billion yuan in total liabilities, with a liability-to-asset ratio of 49.5%.